MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 74 filers reported holding MEREO BIOPHARMA GROUP PLC in Q4 2021. The put-call ratio across all filers is 4.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $282,342 | -29.2% | 218,870 | -27.5% | 0.00% | – |
| Q2 2023 | $398,508 | +637.6% | 301,900 | +295.7% | 0.00% | – |
| Q1 2023 | $54,031 | +449.9% | 76,289 | +482.4% | 0.00% | – |
| Q4 2022 | $9,825 | -93.9% | 13,100 | -93.0% | 0.00% | – |
| Q3 2022 | $161,000 | -27.1% | 186,625 | -5.4% | 0.00% | – |
| Q2 2022 | $221,000 | +325.0% | 197,179 | +326.8% | 0.00% | – |
| Q1 2022 | $52,000 | -82.3% | 46,200 | -74.8% | 0.00% | – |
| Q4 2021 | $294,000 | -27.4% | 183,274 | +9.5% | 0.00% | – |
| Q3 2021 | $405,000 | -13.8% | 167,382 | +12.9% | 0.00% | – |
| Q2 2021 | $470,000 | -28.6% | 148,229 | -24.0% | 0.00% | – |
| Q1 2021 | $658,000 | – | 195,054 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 16,756,120 | $18,767,000 | 0.99% |
| Clearline Capital LP | 3,058,596 | $3,426,000 | 0.44% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 9,142,067 | $10,239,000 | 0.39% |
| DAFNA Capital Management LLC | 1,096,513 | $1,228,000 | 0.34% |
| Octagon Capital Advisors LP | 1,000,000 | $1,120,000 | 0.30% |
| Rock Springs Capital Management LP | 6,230,275 | $6,978,000 | 0.20% |
| Boxer Capital, LLC | 2,250,000 | $2,520,000 | 0.16% |
| Orbimed Advisors | 7,109,954 | $7,963,000 | 0.14% |
| Artal Group S.A. | 1,500,000 | $1,680,000 | 0.09% |
| SECTORAL ASSET MANAGEMENT INC | 385,000 | $431,000 | 0.09% |